Three-dimensional growth reveals fine-tuning of 5-lipoxygenase by proliferative pathways in cancer

Life Sci Alliance. 2023 Feb 27;6(5):e202201804. doi: 10.26508/lsa.202201804. Print 2023 May.

Abstract

The leukotriene (LT) pathway is positively correlated with the progression of solid malignancies, but the factors that control the expression of 5-lipoxygenase (5-LO), the central enzyme in LT biosynthesis, in tumors are poorly understood. Here, we report that 5-LO along with other members of the LT pathway is up-regulated in multicellular colon tumor spheroids. This up-regulation was inversely correlated with cell proliferation and activation of PI3K/mTORC-2- and MEK-1/ERK-dependent pathways. Furthermore, we found that E2F1 and its target gene MYBL2 were involved in the repression of 5-LO during cell proliferation. Importantly, we found that this PI3K/mTORC-2- and MEK-1/ERK-dependent suppression of 5-LO is also existent in tumor cells from other origins, suggesting that this mechanism is widely applicable to other tumor entities. Our data show that tumor cells fine-tune 5-LO and LT biosynthesis in response to environmental changes repressing the enzyme during proliferation while making use of the enzyme under cell stress conditions, implying that tumor-derived 5-LO plays a role in the manipulation of the tumor stroma to quickly restore cell proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonate 5-Lipoxygenase* / genetics
  • Colonic Neoplasms*
  • Humans
  • Lipid Metabolism
  • Mechanistic Target of Rapamycin Complex 2
  • Phosphatidylinositol 3-Kinases

Substances

  • Arachidonate 5-Lipoxygenase
  • Mechanistic Target of Rapamycin Complex 2
  • Phosphatidylinositol 3-Kinases